This article is in need of attention from an expert on the subject. WikiProject Pharmacology or the Pharmacology Portal may be able to help recruit one. (November 2008)

Protein-bound paclitaxel is an injectable formulation of paclitaxel, a mitotic inhibitor drug used in the treatment of breast cancer.^[1] In this formulation, paclitaxel is bonded to albumin as a delivery vehicle. It is sold in the United States under the trade name Abraxane by Abraxis Bioscience.^[2]

This treatment was approved by the Food and Drug Administration in January 2005 for cases where cancer did not respond to other chemotherapy or has relapsed.^[3]

Abraxane is a first^{[citation needed]} in its class of drugs using nanoparticle albumin bound (nab) technology platform.nab Technology

[edit] References

This pharmacology-related article is a stub. You can help Wikipedia by expanding it. v • d • e